Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice
- 18 March 2020
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 57 (6) , 2509-2520
Abstract
CYP2D metabolizes many drugs that act within the brain, and variable expression of CYP2D in the brain may alter local drug and metabolite levels sufficiently to affect behavioral responses. Transgenic mice that express human CYP2D6 (TG) were compared to wild type mice (WT). Following selective inhibition of human CYP2D6 in TG brain, we demonstrated in vivo that human CYP2D6 in the brain was sufficient to alter a drug-induced behavioral response. After a 4-h pre-treatment with intracerebroventricular (i.c.v.) propranolol, CYP2D activity in vivo and in vitro was reduced in TG brain, whereas CYP2D activity in vivo, but not in vitro, was reduced in WT brain. After a 24-h pre-treatment with i.c.v. propranolol, CYP2D activity in vivo and in vitro was reduced in TG brain, whereas CYP2D activity in vivo and in vitro was not changed in WT brain. These results indicate that i.c.v. propranolol irreversibly inhibited human CYP2D6 in TG brain but not mouse CYP2D in TG and WT brain. Pre-treatments with propranolol did not change liver CYP2D activity in vivo or in vitro. Furthermore, 24-h pre-treatment with i.c.v. propranolol resulted in a significant decrease of the haloperidol-induced catalepsy response in TG, but not in WT, without changing serum haloperidol levels in either mouse line. These studies reveal a new tool to selectively and irreversibly inhibit human CYP2D6 in TG brain and indicate that human CYP2D6 has a functional role within the brain sufficient to impact the central nervous system response from peripherally administered drugs.Keywords
Funding Information
- Canada Research Chairs (000)
- Canadian Institutes of Health Research (FDN 154294, FRN 132557)
- Campbell Family Mental Health Research Institute (000)
- Centre for Addiction and Mental Health (000)
This publication has 66 references indexed in Scilit:
- Cytochrome P450–mediated drug metabolism in the brainJournal of Psychiatry and Neuroscience, 2013
- Tissue Distribution and Gender-Divergent Expression of 78 Cytochrome P450 mRNAs in MiceToxicological Sciences, 2011
- Functional Expression and Comparative Characterization of Nine Murine Cytochromes P450 by Fluorescent Inhibition ScreeningDrug Metabolism and Disposition, 2008
- EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF MOUSE CYP2D22Drug Metabolism and Disposition, 2006
- IN VITRO-IN VIVO EXTRAPOLATION OF CYP2D6 INACTIVATION BY PAROXETINE: PREDICTION OF NONSTATIONARY PHARMACOKINETICS AND DRUG INTERACTION MAGNITUDEDrug Metabolism and Disposition, 2005
- Dopamine Formation from Tyramine by CYP2D6Biochemical and Biophysical Research Communications, 1998
- Extrahepatic Metabolism of Drugs in HumansClinical Pharmacokinetics, 1994
- A Novel P450 Expressed at the High Level in Rat BrainBiochemical and Biophysical Research Communications, 1993
- The Human Hepatic Cytochromes P450 Involved in Drug MetabolismCritical Reviews in Toxicology, 1992
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983